Physician profile
Michael W Cook
NPI 1598984825
$2,287.16
in general payments reported to CMS, 2019-2025
22 companies · $439 in 2025
The $439 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $28.31 · 2021: $299 · 2022: $379 · 2023: $207 · 2024: $459 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $780.45 | 2022-2025 | Botox, Ubrelvy |
| Boston Scientific Corporation | $310.35 | 2019-2025 | General - Pain Management |
| Medtronic USA, INC. | $241.18 | 2019-2020 | |
| Si-Bone, INC. | $113.98 | 2019 | |
| Allergan, INC. | $113.93 | 2019-2022 | |
| Vertos Medical, INC. | $95.80 | 2024 | Mild Device Kit |
| Nalu Medical, INC. | $81.90 | 2021 | |
| Stimwave Technologies Incorporated | $80.36 | 2019 | |
| Medtronic, INC. | $74.86 | 2021-2025 | Ligasure, Intellis Adaptivestim |
| Intrinsic Therapeutics | $74.62 | 2022 | |
| Painteq LLC | $56.39 | 2024 | Painteq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.80 | 2021 | |
| Spr Therapeutics, INC | $34.21 | 2025 | Sprint Pns System |
| Alexion Pharmaceuticals, INC. | $30.66 | 2024 | Ultomiris |
| Takeda Pharmaceuticals U.S.A., INC. | $26.22 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.45 | 2025 | Eterna |
| Nevro Corp. | $21.55 | 2021 | |
| Merck Sharp & Dohme LLC | $19.90 | 2025 | Prevymis |
| Daiichi Sankyo INC. | $17.44 | 2025 | Injectafer |
| Collegium Pharmaceutical, INC. | $15.06 | 2024 | Belbuca |
| Pfizer INC. | $14.50 | 2019 | |
| Relievant Medsystems, INC. | $11.55 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.